JPRN-UMIN000002469招募中未知
Cholesterol lowerling effect of ezetimibe on hypercholesterolemic patients with type2 diabetes. - Zetia study
Department of Metabolic Medicine, Graduate School of Medical Science, Kumamoto University.0 个研究点目标入组 30 人开始时间: 2009年9月8日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. patients with cerebrovasucular disease (onset within 12 weeks). 2. patients over 500 mg/dl of TG. 3. patients with cardiovascular disease. 4. patients with liver disfunction. 5. patients with renal disfunction. 6. patients who are estimated not to continue this study by serious diseases. 7. patients with familial hypercholesterolemia. 8. secondary hypercholesterolemia. 9. patients with alcholism or medicinal poisoning. 10. medicinal allergy. 11. patients with pregnancy.
研究者
相似试验
已完成
不适用
The effect of Ezetimibe in hypercholesterolemic patients with Nonaicoholic fatty liver disease(NAFLD)onaicoholic fatty liver diseaseJPRN-UMIN000002440Saiseikai Suita Hospital50
已完成
不适用
Effect of ezetimibe in hypercholesterolemic patient with glucose toleranceDyslipidemiaJPRN-UMIN000004091Chigasaki Municipal Hospital150
已完成
不适用
The lowering effect of ezetimibe on serum lipids and serum lipoprotein in postprandial hyperlipidemiType 2 diabetes mellitus with hyperlipidemiaJPRN-UMIN000013611akakinen clinic35
已完成
不适用
Effect of ezetimibe on small dense LDL and fatty acids in patients treated with a statin and omega-3 fatty acids supplimentatioDyslipidemiaJPRN-UMIN000012589Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences30
已完成
不适用
Effects of ezetimibe on postprandial hyperlipidemia.dyslipidemiaJPRN-UMIN000003392Juntendo University School of Medicine, Cardiology30